Longakit A, Urtatiz O, Luty A, Zhang C, Hess C, Yoo A
Cancer Res Commun. 2025; 5(2):209-225.
PMID: 39804140
PMC: 11788999.
DOI: 10.1158/2767-9764.CRC-24-0386.
White E, Rhodes S
Cancers (Basel). 2024; 16(5).
PMID: 38473354
PMC: 10930863.
DOI: 10.3390/cancers16050994.
Furnari F, Anastasaki C, Bian S, Fine H, Koga T, Le L
Dis Model Mech. 2024; 17(2).
PMID: 38353122
PMC: 10886724.
DOI: 10.1242/dmm.050533.
Hernandez D, Cruz D, Martinez C, Garcia L, Figueroa A, Villarreal M
Cancers (Basel). 2024; 16(3).
PMID: 38339230
PMC: 10854893.
DOI: 10.3390/cancers16030477.
Tian Z, Du Z, Bai G, Gong Q, You Y, Xu G
Cancer Gene Ther. 2024; 31(4):627-640.
PMID: 38302728
DOI: 10.1038/s41417-024-00727-1.
[Gene therapy strategies and prospects for neurofibromatosis type 1].
Zheng T, Zhu B, Wang Z, Li Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024; 38(1):1-8.
PMID: 38225833
PMC: 10796236.
DOI: 10.7507/1002-1892.202309071.
Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.
Jiang C, Kumar A, Yu Z, Shipman T, Wang Y, McKay R
J Clin Invest. 2023; 133(12).
PMID: 37140985
PMC: 10266775.
DOI: 10.1172/JCI168227.
Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.
Ge L, Xing M, Zhang H, Wang Z
Cancers (Basel). 2022; 14(18).
PMID: 36139671
PMC: 9497298.
DOI: 10.3390/cancers14184513.
A genetic mouse model with postnatal and loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.
Inoue A, Janke L, Gudenas B, Jin H, Fan Y, Pare J
Neurooncol Adv. 2021; 3(1):vdab129.
PMID: 34647023
PMC: 8500687.
DOI: 10.1093/noajnl/vdab129.
Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.
Ishii A, Furusho M, Bansal R
Glia. 2021; 69(10):2429-2446.
PMID: 34157170
PMC: 8373720.
DOI: 10.1002/glia.24049.
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
Osum S, Watson A, Largaespada D
Int J Mol Sci. 2021; 22(4).
PMID: 33669386
PMC: 7920315.
DOI: 10.3390/ijms22041954.
Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J, Anastasaki C, Chen Z, Shipman T, Papke J, Yin K
J Clin Invest. 2020; 131(1).
PMID: 33108355
PMC: 7773354.
DOI: 10.1172/JCI139807.
Brain-wide structural and functional disruption in mice with oligodendrocyte-specific deletion is rescued by inhibition of nitric oxide synthase.
Asleh J, Shofty B, Cohen N, Kavushansky A, Lopez-Juarez A, Constantini S
Proc Natl Acad Sci U S A. 2020; 117(36):22506-22513.
PMID: 32839340
PMC: 7486714.
DOI: 10.1073/pnas.2008391117.
Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST.
Chaney K, Perrino M, Kershner L, Patel A, Wu J, Choi K
Cancer Res. 2020; 80(21):4720-4730.
PMID: 32816910
PMC: 7968129.
DOI: 10.1158/0008-5472.CAN-19-1429.
A molecular basis for neurofibroma-associated skeletal manifestations in NF1.
Ma Y, Gross A, Dombi E, Pemov A, Choi K, Chaney K
Genet Med. 2020; 22(11):1786-1793.
PMID: 32601387
PMC: 8106869.
DOI: 10.1038/s41436-020-0885-3.
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.
Mund J, Park S, Smith A, He Y, Jiang L, Hawley E
J Biol Chem. 2020; 295(29):9948-9958.
PMID: 32471868
PMC: 7380178.
DOI: 10.1074/jbc.RA119.010981.
Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.
Grit J, Pridgeon M, Essenburg C, Wolfrum E, Madaj Z, Turner L
Genes (Basel). 2020; 11(3).
PMID: 32245042
PMC: 7141129.
DOI: 10.3390/genes11030331.
The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.
Na Y, Huang G, Wu J
Mol Cells. 2020; 43(2):153-159.
PMID: 31940719
PMC: 7057834.
DOI: 10.14348/molcells.2019.0295.
Mitochondrial Dysfunction Leads to Cortical Under-Connectivity and Cognitive Impairment.
Fernandez A, Meechan D, Karpinski B, Paronett E, Bryan C, Rutz H
Neuron. 2019; 102(6):1127-1142.e3.
PMID: 31079872
PMC: 6668992.
DOI: 10.1016/j.neuron.2019.04.013.
Spatiotemporal Loss of in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway.
Chen Z, Mo J, Brosseau J, Shipman T, Wang Y, Liao C
Cancer Discov. 2018; 9(1):114-129.
PMID: 30348677
PMC: 6328325.
DOI: 10.1158/2159-8290.CD-18-0151.